IL2 and neoplasm: Specifically, BBL-28.mζ CAR T-cells released higher levels of IFNγ, IL2, and GMCSF at first and fourth stimulations with GL261 tumor cells (Fig. 2C–E, BBL-28.mζ vs. other constructs P < 0.05).